GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » Current Accrued Expense

Tecogen (Tecogen) Current Accrued Expense : $2.68 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tecogen Current Accrued Expense?

Tecogen's Current Accrued Expense for the quarter that ended in Mar. 2024 was $2.68 Mil.

Tecogen's quarterly Current Accrued Expense declined from Sep. 2023 ($2.63 Mil) to Dec. 2023 ($2.51 Mil) but then increased from Dec. 2023 ($2.51 Mil) to Mar. 2024 ($2.68 Mil).

Tecogen's annual Current Accrued Expense increased from Dec. 2021 ($2.34 Mil) to Dec. 2022 ($2.38 Mil) and increased from Dec. 2022 ($2.38 Mil) to Dec. 2023 ($2.51 Mil).


Tecogen Current Accrued Expense Historical Data

The historical data trend for Tecogen's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen Current Accrued Expense Chart

Tecogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.60 1.99 2.34 2.38 2.51

Tecogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.24 2.55 2.63 2.51 2.68

Tecogen Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Tecogen Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tecogen's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecogen (Tecogen) Business Description

Traded in Other Exchanges
Address
45 First Avenue, Waltham, MA, USA, 02451
Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.
Executives
Earl R Lewis director C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos director, 10 percent owner, officer: Chief Executive Officer 85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch director 280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh director, officer: Chief Financial Officer 45 FIRST AVE, WALTHAM MA 02451
John M Albertine director 100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown 10 percent owner, other: Trustee C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins director 45 FIRST AVE, WALTHAM MA 02451
Fred Holubow director
Locke M. Benjamin officer: Co-CEO 45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv officer: General Counsel & Secretary 49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen director 45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas 10 percent owner TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell director 6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson director C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison officer: CFO, Treasurer and Secretary C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420

Tecogen (Tecogen) Headlines